Parmax Pharma Ltd - 540359 - CERTIFICATE FROM PRACTICING COMPANY SECRETARY UNDER SEBI REGULATION 40(9)
CERTIFICATE REQUIRED FOR THE COMPLIANCE OF REGULATION 40(9) / (10) OF SEBI (LODR), 2015 FOR THE YEAR ENDED ON 31/03/2024.29-04-2024
29-04-2024
Parmax Pharma Ltd - 540359 - Compliance Certificate Pursuant To Regulation 7(3)
Compliance Certificate pursuant to Regulation 7(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 for the year ended on 31st March, 202412-04-2024
Parmax Pharma Ltd - 540359 - Compliance Certificate Pursuant To Regulation 7(3)
Compliance Certificate pursuant to Regulation 7(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 for the year ended on 31st March, 202412-04-2024
Parmax Pharma Ltd - 540359 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
certificate under regulation 74(5) SEBI (Depositories and Participants) regulations, 2018, For the quarter ended on 31st March, 2024.07-04-2024
Parmax Pharma Ltd - 540359 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding loss of share certificates02-04-2024
Parmax Pharma Ltd - 540359 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss share certificates20-02-2024
Parmax Pharma Ltd - 540359 - Board Meeting Outcome for Financial Results For Quarter And Nine Months Ended 31.12.2023
Financial results for quarter and nine months ended 31.12.202314-02-2024
Parmax Pharma Ltd - 540359 - Financial Results For Quarter And Nine Months Ended 31.12.2023
Financial statements for quarter and nine months ended on 31.12.202314-02-2024
Parmax Pharma Ltd - 540359 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimationm of loss of share certificate07-02-2024